NASDAQ:APM - Nasdaq - KYG6096M1226 - Common Stock - Currency: USD
Overall APM gets a fundamental rating of 1 out of 10. We evaluated APM against 555 industry peers in the Biotechnology industry. Both the profitability and financial health of APM have multiple concerns. APM is valued correctly, but it does not seem to be growing.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -26.46% | ||
ROE | -20.19% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Altman-Z | -8.12 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 0.22 | ||
Quick Ratio | 0.22 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | 0.02 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
NASDAQ:APM (6/27/2025, 8:00:00 PM)
0.9715
-0.02 (-1.87%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | 0.02 | ||
P/S | N/A | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 0.33 | ||
P/tB | 0.33 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -26.46% | ||
ROE | -20.19% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | N/A | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | N/A | ||
Cap/Sales | N/A | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 0.22 | ||
Quick Ratio | 0.22 | ||
Altman-Z | -8.12 |